NCT01734681View on ClinicalTrials.gov

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Prostate Cancer.
Interventions
DRUG

G-202

Trial Locations (1)

78229-3900

The University of Texas Health Science Center, San Antonio

Sponsors

Lead Sponsor

GenSpera, Inc.
All Listed Sponsors
lead

GenSpera, Inc.

INDUSTRY